(10R,13R)-17-(6-Hydroxy-5-methylheptan-2-yl)-10, 13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,-16,17-tetradecahydro-1H-cyclopenta[a] The title tetracyclic steroidal compound, C 27 H 46 O 2 Á0.5H 2 O, crystallized as a monohydrate with two independent molecules (1 and 2) in the asymmetric unit. In both molecules, the conformations of the three cyclohexane rings (A, B and C) are chair, half-chair and chair, respectively. The fourth ring, D, has a twisted conformation on the bond linking the D and C rings. The crystal structure is stabilized by hydrogen bonding with the two independent molecules being linked through the solvent water molecule via various O-HÁ Á ÁO hydrogen bonds, forming layers parallel to (101).
Structure description
The title compound was isolated from a methanol extract of the herb A. reticulata (in local dialect Kirmani aajowan) by column chromatography (CC) over SiO 2 gel by gradient solvent elution. This herb has been credited with different kinds of pharmacological activities, and has been used as a folklore medicine for conventional therapy against various ailments: malaria (Klayman et al., 1984; Malagon et al., 1997; Newton & White, 1999) , cancer (Efferth et al., 2001; Lai & Singh, 1995) , cardiovascular (Guantai & Addae-Mensah, 1999) , vasodilatory (Walker, 1996) , hepatitis (Aniya et al., 2000) and diabetes (Iriadam et al., 2006) . It is found as a major constituent in many ayurvedic and herbal drug preparations, such as forkolin, Afsanteen and others, in Indian traditional data reports medicinal systems (Nadkarni, 1954; Satyavati et al., 1987; Subramoniam et al., 1996; Drury, 1978) . The Artemisia species are a rich source of bioactive sesquiterpenenoids (Klayman et al., 1984) , such as artemisin and artemisinin, and secondary metabolites isolated from A. annua (Klayman, 1985) exhibit antiplasmodial activity (Li et al., 1982) . It is also under clinical trials to eradicate malaria.
We are looking for alternative abundant sources of artemisin and artemisinin from other varieties of Artemisia species. Unfortunately, phytochemical investigations revealed that the species of A. reticulata used by us did not possess the aforesaid terpenoids. Instead of that, a colourless solid substance was isolated as a minor constituent by column chromatographic separation. Herein, we report on the extraction and crystal structure of this minor colourless solid constituent assigned as a tetracyclic steroid based on chemical evidence. This solid substantiated the LB test (Liebermann Burchard Test), and a colour reaction on spraying with 10% aqueous H 2 SO 4 onto a micro TLC plate followed by heating at 393 K for 5 min developed a pink-coloured spot on the TLC. These chemical tests revealed that the compound is a steroid. It shows a very close structural resemblance to the cyclopenteno perhydrophenanthreen skeleton viz. cholesterol (Craven, 1976; Marc, 1979; Naora et al., 1986) , but with different substituents.
The molecular structure of the title compound is illustrated in Fig. 1 . It crystallizes as a monohydrate with two independent molecules (1 and 2) in the asymmetric unit. The two molecules are almost identical ( Fig. 2 ) and here the geometry will be described for molecule 1 only. It has an alkyl (1-hydroxy-2-isopropylhexyl) side chain located at atom C17 of the cyclopentane D ring. This side chain undergoes considerable thermal liberation and bond strain. The molecule is composed of a series of fused rings (A, B, C and D). Rings A and C have chair conformations while ring B has a half-chair conformation, and the five-membered ring D is twisted on bond C13-C14. In addition to the tetracyclic moiety, two -CH 3 groups are present at positions C5 and C13, at ring junctures A/B and C/ D, respectively. At atom C2 in ring A there is an -OH group and in ring D the alkyl side chain, (1-hydroxy-2-isopropylhexyl), at atom C17. The molecular structure of the title compound, with the atom labelling and displacement ellipsoids drawn at the 50% probability level.
There is total of eleven asymmetric centres in the title molecule at various positions, such as C2, C5, C9, C10, C13, C14, C17, C20, C24 and C25. Among them, five asymmetric centres located at carbon atoms C2, C9, C10, C14, C25, and the remaining six chiral centres located at atoms C5, C13, C17, C20, C24, have relative S and R configurations, respectively; see Fig. 3 .
In the crystal, molecules are linked via O-HÁ Á ÁO water , O water -HÁ Á ÁO and other O-HÁ Á ÁO hydrogen bonds, forming layers lying parallel to (101); see Table 1 and Figs. 4 and 5.
Synthesis and crystallization
The title steroid was isolated as a colourless solid from a methanol extract of A. reticulata by means of CC/SiO 2 gel by gradient elution with a mixture of a binary solvent system, hexane and ethyl acetate. The desired compound was purified by reverse-phase high-pressure liquid chromatography. Suitable crystals for X-ray diffraction were obtained after being recrystallized three times from ethyl acetate:hexane (1:4) at room temperature by slow evaporation of the solvents.
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 . In both molecules the alkyl (1-hydroxy-2-isopropylhexyl) side chain located at atom C17 of the cyclopentane D ring undergoes considerable thermal liberation and bond strain, and it was necessary to use a number of ISOR, DELU and DFIX restraints during the refinement process. Nevertheless, the final R factors are still relatively high: R[ (Sheldrick, 2008) , SHELXL2014 (Sheldrick, 2015) and PLATON (Spek, 2009) . Table 1 Hydrogen-bond geometry (Å , ). (7) 2.07 (9) 2.834 (9) 147 ( 
Figure 5
A view along the a axis of the crystal packing of the title compound (molecule 1 blue, molecule 2 red). The O-HÁ Á ÁO hydrogen bonds are shown as dashed lines (Table 1) , and only the water molecule and hydroxy H atoms have been included.
data-1
IUCrData ( Special details Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. (7) data-6 (5 
